glutathione synthesis inhibitor Combined inhibition of de novo
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect Frontiers Preclinical investigations of the efficacy of the glutaminase inhibitor CB 839 alone and in combinations in chronic lymphocytic leukemia The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Glutathione Synthesis in Cancer Cells Biochemistry (Moscow) Springer Nature Link Study proposes a new strategy to intervene glutathione metabolism in the treatment of glioma Creative Peptides Blog
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




